Company News

Monday 09 July, 2018 | RSS Feed

Scientists use magnets resisting depression

by AOMag | post a comment

7he incidence of depression and the use of antidepressants were high in 2017, and about one-third of the patients did not work after receiving treatment. For them, transcranial magnetic stimulation (TMS) – with strong The magnets are non-invasively stimulating the treatment of brain cells - perhaps a viable option.
In fact, TMS is not a new treatment, and the US Food and Drug Administration approved the therapy in 2008. One of the novelties is the growing evidence of the safety and efficacy of the therapy. According to the World Health Organization, about 350 million people worldwide suffer from depression, making it one of the leading causes of disability worldwide. Up to 30% of people with depression are reluctant to receive treatment and show suicidal thoughts and attempts, resulting in poor overall quality of life.
Depression is plaguing the 63-year-old retired nurse Brenda Griffith. Griffith was diagnosed with the disease by the psychiatrist James Beeghly in the early 1990s, after which she received almost every antidepressant drug prescription.
Antidepressant drugs are the most common treatments in related treatments. However, Griffith has refractory depression, which means that patients still have symptoms after two or more treatments for antidepressants.
As an alternative, Griffith has used electroconvulsive therapy (ECT), an invasive therapy that allows current to pass through the brain to treat more severe depression. "ETC saved my life, but it didn't make me back to normal, I had to give up nursing work," she said. To this end, she chose TMS. In transcranial magnetic stimulation therapy, a small electromagnetic coil is placed at a precise location on the patient's head. For people with depression, this position is the left frontal cortex of the brain, which is usually less active. Compared to ECT, TMS is characterized by non-invasiveness. When TMS was first applied to the clinic, many people were hesitant about the therapy because of safety concerns. However, recent studies have shown that the therapy has no obvious safety concerns. “Non-invasive refers to the fact that no surgery is required,” says Aaron Boes, an expert at TMS at Iowa State University. “In fact, there are many safety data for TMS, and patients have no significant cognitive negative effects and risk of epilepsy. Less than 0.1%."





News for Friday 04 May, 2018


View all news for Friday 04 May, 2018 on one page




Recent News




News archive